CompaniesClanotech

Clanotech

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

5

As Collaborator

0

Total Enrollment

154

By Phase

NA: 4

By Status

TERMINATED: 2RECRUITING: 1ACTIVE_NOT_RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
NCT03736655
NCT04770324
NCT05159817
NCT05236439
NCT05625958
Hover over trial bars to see details

Recent Trials

NCT05625958Lead Sponsor
Clinical Study Evaluating the Efficacy and Safety of CID v2.2 in Glaucoma Surgery
NARecruiting
29 participants
Started: Mar 23, 2023 · Completed: Sep 1, 2028
NCT05236439Lead Sponsor
Study of a Cilioscleral Interposition Device (CID) SV22 in Patients With Primary Open Angle Glaucoma and Narrow Angle Glaucoma
NAActive, not recruiting
57 participants
Started: May 23, 2022 · Completed: Dec 15, 2025
NCT05159817Lead Sponsor
Study of an Interposition Supraciliary Implant in Patients With Open Angle Glaucoma
N/AUnknown
19 participants
Started: Dec 15, 2021 · Completed: Dec 31, 2024
NCT04770324Lead Sponsor
Study of a Novel Interposition Supraciliary Implant in Patients With Open Angle Glaucoma (SAFARI 2)
NATerminated
22 participants
Started: Apr 23, 2021 · Completed: Jul 26, 2024
NCT03736655Lead Sponsor
Study of a Novel Interposition Supraciliary Implant in Patients With Open Angle Glaucoma
NATerminated
27 participants
Started: Mar 15, 2019 · Completed: Oct 25, 2021